LISINOPRIL-INDUCED HYPERPIGMENTATION

Simple item page
dc.creatorYang, Robert
dc.date.accessioned2022-07-05T15:08:40Z
dc.date.available2022-07-05T15:08:40Z
dc.date.issued2013-04-12
dc.description.abstractPurpose: For patients with hypertension, cardiovascular disease, and diabetes, lisinopril is a commonly prescribed angiotensin-converting enzyme (ACE) inhibitor. While known to have adverse cutaneous reactions such as pruritus and angioedema, we present a case of hyperpigmenting, desquamating rash in a 54 year-old African American woman. Methods: The information was gathered from patient chart review. Results: Upon discontinuation of lisinopril, the subject's rash resolved. Conclusions: For patients on ACE inhibitors, development of a hyperpigmenting, desquamating rash should considered an adverse cutaneous reaction.
dc.identifier.urihttps://hdl.handle.net/20.500.12503/31487
dc.subjectACE Inhibitors
dc.subjectAdverse Reaction
dc.subjectHyperpigmentation
dc.titleLISINOPRIL-INDUCED HYPERPIGMENTATION
dc.typeposter
dc.type.materialtext

Files

Collections

Case Presentation